Location: Home >> Construction of Information Management System for Adverse Reactions of Chemotherapy Drugs
In order to promote the monitoring of adverse reactions of chemotherapy drugs and provide a reference for ensuring the rational application of chemotherapy drugs, this paper designs an information management system for adverse reactions of chemotherapy drugs based on the hospital information management system and clinical inspection information system. Monitoring warning, statistical analysis as the main function of chemotherapy drug hematological adverse reaction monitoring software, and the implementation of hematological adverse reaction monitoring function of commonly used lung cancer chemotherapy drugs. Successfully correlated patient medication information with test data, realized the monitoring of hematological adverse reactions and the warning of serious adverse reactions, and played an active role in ensuring patient medication safety, promoting the rational application of chemotherapy drugs, and further evaluating the safety of new chemotherapy drugs.
[1] Yong M A, Jian-Jun H E, Liu B , et al. Construction and Application of Adverse Drug Reaction Evaluation Standard System in Our Hospital [J]. China Health Industry, 2017.
[2] Huang H F, Hui-Min L U, Deng Y , et al. Construction of Integrated Management and Application System of Information Data of Chinese Medicine at the Grass-roots Level-Take the Chinese Patent Medical Product Database As An Example [J]. Guiding Journal of Traditional Chinese Medicine and Pharmacy, 2018.
[3] Yang L, Piaoping H U, Chenggao W U, et al. Construction of intelligent path for adverse transfusion reactions and its clinical application [J]. Chinese Journal of Blood Transfusion, 2017.
[4] Meijuan X U, Lin H, Jianwen Y E, et al. Analysis and prevention cure monitoring of intravenous chemotherapy for adverse drug reactions [J]. China Medical Herald, 2016.
[5] Leo M, Cini E, Pugi A, et al. GRP-188 Under-Reporting of Adverse Drug Reactions in the Hospital Setting: An Estimate Based on the Analysis of Hospital Discharge Records [J]. European Journal of Hospital Pharmacy Science & Practice, 2013, 20(Suppl 1):A67.3-A68.
[6] Shuai L I, Chen R L. Adverse Reactions and Pharmaceutical Care of First Line Chemotherapy of Lung Cancer [J]. Drug Evaluation, 2017.
[7] Kazuhiro T, Toshifumi O. Management of elderly patients with bone and soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group [J]. Japanese Journal of Clinical Oncology, 2022(6):6.
[8] Yan-Gui X U, Pharmacy D O. Research progress on therapy for extravasation due to chemotherapy drugs for cancer [J]. Adverse Drug Reactions Journal, 2013, 15(6):346-349.
[9] Demuth D C, CR Müntener, Althaus F R. CliniPharm: an information system for the pharmacotherapy of horses [J]. Der Prak-tische Tierarzt, 2009, 90(8):732-739.
Shuzhi Xue, Li He, Min Zhang. Construction of Information Management System for Adverse Reactions of Chemotherapy Drugs. International Journal of Medicine Frontiers, 2022, 5(1), 15-20.
Copyright © 2022 Damray Co., Ltd. Privacy Policy | Terms and Conditions
